DE69636837D1 - 1,2,4-benzotriazinoxid-formulierungen - Google Patents

1,2,4-benzotriazinoxid-formulierungen

Info

Publication number
DE69636837D1
DE69636837D1 DE69636837T DE69636837T DE69636837D1 DE 69636837 D1 DE69636837 D1 DE 69636837D1 DE 69636837 T DE69636837 T DE 69636837T DE 69636837 T DE69636837 T DE 69636837T DE 69636837 D1 DE69636837 D1 DE 69636837D1
Authority
DE
Germany
Prior art keywords
benzotriazine
formulations
benzotriazine formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636837T
Other languages
English (en)
Other versions
DE69636837T2 (de
Inventor
Stephen Brown
Edward Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis US LLC
Original Assignee
Sanofi Aventis US LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis US LLC filed Critical Sanofi Aventis US LLC
Publication of DE69636837D1 publication Critical patent/DE69636837D1/de
Application granted granted Critical
Publication of DE69636837T2 publication Critical patent/DE69636837T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69636837T 1995-09-25 1996-08-21 1,2,4-benzotriazinoxid-formulierungen Expired - Fee Related DE69636837T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53342495A 1995-09-25 1995-09-25
US533424 1995-09-25
PCT/US1996/013550 WO1997011699A1 (en) 1995-09-25 1996-08-21 1,2,4-benzotriazine oxides formulations

Publications (2)

Publication Number Publication Date
DE69636837D1 true DE69636837D1 (de) 2007-02-22
DE69636837T2 DE69636837T2 (de) 2007-10-25

Family

ID=24125899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636837T Expired - Fee Related DE69636837T2 (de) 1995-09-25 1996-08-21 1,2,4-benzotriazinoxid-formulierungen

Country Status (16)

Country Link
EP (1) EP0866709B1 (de)
JP (1) JPH11511479A (de)
KR (1) KR100514009B1 (de)
CN (1) CN100366253C (de)
AU (1) AU718268B2 (de)
CA (1) CA2232989C (de)
CZ (1) CZ292102B6 (de)
DE (1) DE69636837T2 (de)
DK (1) DK0866709T3 (de)
ES (1) ES2277347T3 (de)
HU (1) HUP9802536A3 (de)
NO (1) NO317157B1 (de)
NZ (1) NZ316340A (de)
PT (1) PT866709E (de)
RU (1) RU2166946C2 (de)
WO (1) WO1997011699A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827850A (en) * 1995-09-25 1998-10-27 Sanofi Pharmaceuticals, Inc. 1,2,4-benzotriazine oxides formulations
US7816521B2 (en) 2004-03-01 2010-10-19 Auckland Uniservices Limited 1,2,4-benzotriazine-1,4-dioxides
CA2567574C (en) 2004-04-08 2013-01-08 Targegen, Inc. Benzotriazine inhibitors of kinases
CA2578283A1 (en) 2004-08-25 2006-03-02 Targegen, Inc. Heterocyclic compounds and methods of use
CN101683346B (zh) * 2008-09-24 2015-04-01 杭州民生药业有限公司 一种替拉扎明非肠道含水制剂及其制备方法
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980779A (en) * 1972-02-01 1976-09-14 Bayer Aktiengesellschaft 3-Amino-1,2,4-benzotriazine-1,4-di-N-oxide compositions and method of using same
US5175287A (en) * 1986-09-25 1992-12-29 S R I International Process for preparing 1,2,4-benzotriazine oxides

Also Published As

Publication number Publication date
NZ316340A (en) 1999-04-29
JPH11511479A (ja) 1999-10-05
HUP9802536A2 (hu) 1999-04-28
DK0866709T3 (da) 2007-03-19
EP0866709A4 (de) 2002-07-17
CZ89898A3 (cs) 1998-11-11
AU718268B2 (en) 2000-04-13
NO981324D0 (no) 1998-03-24
WO1997011699A1 (en) 1997-04-03
EP0866709B1 (de) 2007-01-10
AU6854896A (en) 1997-04-17
NO981324L (no) 1998-05-25
HUP9802536A3 (en) 2000-02-28
KR100514009B1 (ko) 2005-11-25
KR19990063735A (ko) 1999-07-26
EP0866709A1 (de) 1998-09-30
CZ292102B6 (cs) 2003-07-16
CA2232989A1 (en) 1997-04-03
MX9802314A (es) 1998-08-30
CN1202827A (zh) 1998-12-23
PT866709E (pt) 2007-02-28
NO317157B1 (no) 2004-08-30
ES2277347T3 (es) 2007-07-01
CA2232989C (en) 2008-01-29
CN100366253C (zh) 2008-02-06
DE69636837T2 (de) 2007-10-25
RU2166946C2 (ru) 2001-05-20

Similar Documents

Publication Publication Date Title
MA23780A1 (fr) Quinazolinones 2, 8 disubstitues
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE69618634D1 (de) 1,4-benzodioxin-derivate
ITMI951395A0 (it) Formulazioni di f-silicone
TR199501082A2 (tr) Farmasötik formülasyonlar.
TR199601012A2 (tr) Sampuan terkibi.
DE69636837D1 (de) 1,2,4-benzotriazinoxid-formulierungen
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
DE29510417U1 (de) Stallanordnung
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
IT1283187B1 (it) "elettrovalvola."
DE59606925D1 (de) 1,6-Naphthyridoncarbonsäurederivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee